Monique Berwaer
16Patents
4h-index
23Co-inventors
56Inventor score
Filing activity: Sep 29, 1999 → Dec 5, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6699502B1 | Pharmaceutical compositions for controlled release of active substances | Human Necessities | 89 | Expired |
| US7083807B2 | Pharmaceutical compositions for the controlled release of active substances | Human Necessities | 20 | Expired |
| US7014867B2 | Tablet comprising cetirizine and pseudoephedrine | Human Necessities | 8 | Expired |
| US7226614B2 | Tablet comprising cetirizine and pseudoephedrine | Human Necessities | 4 | Expired |
| US6455533B1 | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin | Performing Operations; Transporting | 3 | Expired |
| US8435564B2 | Pharmaceutical compositions comprising brivaracetam | Human Necessities | 3 | Active |
| US8460712B2 | Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate | Human Necessities | 2 | Active |
| US6262057A | Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride | Human Necessities | 2 | Expired |
| US8981094B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 1 | Active |
| US8946228B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US8946229B2 | Formulations | Human Necessities | 0 | Active |
| US10729653B2 | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives | Human Necessities | 0 | Active |
| US10172805B2 | Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative | Chemistry; Metallurgy | 0 | Active |
| US9227935B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US8563036B2 | Pharmaceutical compositions comprising Brivaracetam | Human Necessities | 0 | Active |
| US6335331B1 | Pseudopolymorphic forms of 2-[2-[4-[Bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.